BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

Among the leading biotech and emerging pharmaceutical companies, Incyte (NASDAQ: INCY ) and Pharmacyclics (NASDAQ: PCYC ) saw the largest percentage declines in short interest between the January 15 and January 31 settlement dates. Short sellers shied away from Alexion Pharmaceuticals, Amgen, Biogen Idec, Dendreon, Medivation, Questcor Pharmaceuticals and